Primary systemic vasculitis with severe α1-antitrypsin deficiency revisited

被引:9
|
作者
Mohammad, A. [1 ,2 ]
Segelmark, M. [3 ,4 ]
机构
[1] Lund Univ, Dept Clin Sci, Rheumatol Sect, Lund, Sweden
[2] Skane Univ Hosp, Dept Rheumatol, SE-22185 Lund, Sweden
[3] Cty Council Ostergotland, Dept Nephrol UHL, Linkoping, Sweden
[4] Linkoping Univ, Dept Med & Hlth Sci, S-58183 Linkoping, Sweden
关键词
ANCA-ASSOCIATED VASCULITIS; DAMAGE INDEX VDI; ALPHA-1-ANTITRYPSIN DEFICIENCY; WEGENERS-GRANULOMATOSIS; POLYARTERITIS-NODOSA; ANTITRYPSIN;
D O I
10.3109/03009742.2013.846405
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To study the clinical characteristics and epidemiology of the combination of primary systemic vasculitis (PSV) and severe alpha-1 antitrypsin (alpha(1)-AT) deficiency. Method: Patients with PSV [granulomatosis with polyangiitis (GPA) (Wegener's), microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis (EGPA) (Churg-Strauss), and polyarteritis nodosa] were identified through diagnosis registries and serological databases. Clinical and laboratory data, including the presence of severe alpha(1)-AT deficiency, were collected from the time of diagnosis. During follow-up, data on relapses and permanent organ damage were collected. Using the county of Skane as the denominator population, we estimated the annual incidence rate and point prevalence of PSV in people with severe alpha(1)-AT deficiency. Results: Five patients (three women, median age 49 years) with PSV diagnosed between 1996 and 2008 were found to have alpha(1)-AT deficiency, all of them carrying the protease inhibitor ZZ (PiZZ) phenotype. During follow-up (median time 166 months, range 53-208), four patients experienced a total of 13 relapses. The median Vasculitis Damage Index (VDI) score for all patients was 3 (range 1-4) at year 1, and 7 (range 3-9) at the last follow-up. The incidence rate of PSV among PiZZ carriers was estimated to be 397/million [95% confidence interval (CI) 8-787]. The point prevalence on 1 January 2013 was estimated to be 4689/million (95% CI 94-9285). Conclusions: In this study both the incidence and prevalence of PSV were elevated nearly 10-fold for individuals with severe alpha(1)-AT deficiency compared with the general population. Combined with previous publications, this indicates a dose-response relationship for the genetic risk and suggests a causal relationship between the PiZ allele and vasculitis.
引用
收藏
页码:242 / 245
页数:4
相关论文
共 50 条
  • [31] Alpha 1-antitrypsin deficiency
    Mornex, J. -F.
    REVUE DES MALADIES RESPIRATOIRES, 2022, 39 (08) : 698 - 707
  • [32] Severe ulcerative panniculitis caused by alpha 1-antitrypsin deficiency: Remission induced and maintained with intravenous alpha 1-antitrypsin
    Al-Niaimi, Firas
    Lyon, Calum
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 65 (01) : 227 - 229
  • [33] ALPHA-1 ANTITRYPSIN DEFICIENCY AND SYSTEMIC NECROTIZING VASCULITIS
    FORTIN, PR
    FRASER, RS
    WATTS, CS
    ESDAILE, JM
    JOURNAL OF RHEUMATOLOGY, 1991, 18 (10) : 1613 - 1616
  • [34] α1-Antitrypsin Polymerizes in Alveolar Macrophages of Smokers With and Without α1-Antitrypsin Deficiency
    Bazzan, Erica
    Tine, Mariaenrica
    Biondini, Davide
    Benetti, Riccardo
    Baraldo, Simonetta
    Turato, Graziella
    Fagiuoli, Stefano
    Sonzogni, Aurelio
    Rigobello, Chiara
    Rea, Federico
    Calabrese, Fiorella
    Foschino-Barbaro, Maria Pia
    Miranda, Elena
    Lomas, David A.
    Saetta, Marina
    Cosio, Manuel G.
    CHEST, 2018, 154 (03) : 607 - 616
  • [35] Compelling evidence for the efficacy of α1-antitrypsin augmentation treatment for α1-antitrypsin deficiency
    Crystal, Ronald G.
    LANCET RESPIRATORY MEDICINE, 2017, 5 (01): : 7 - 8
  • [36] Enigma of α1-antitrypsin:: α1-antitrypsin deficiency reveals a puzzling physiological function
    Nukiwa, T
    INTERNAL MEDICINE, 2001, 40 (04) : 271 - 272
  • [37] Progress of emphysema in severe α1-antitrypsin deficiency as assessed by annual CT
    Dept. of Resp. Med. and of Radiology, Bispebjerg Hospital, Copenhagen, Denmark
    不详
    不详
    不详
    Acta Radiol., 5 (826-832):
  • [38] The bronchopulmonary pathology of alpha 1-antitrypsin (AAT) deficiency: Findings of the death review committee of the national registry for individuals with severe deficiency of alpha 1-antitrypsin
    Tomashefski, JF
    Crystal, RG
    Wiedemann, HP
    Mascha, E
    Stoller, JK
    LABORATORY INVESTIGATION, 2003, 83 (01) : 315A - 315A
  • [39] Severe alpha 1-antitrypsin deficiency diagnosed at 73 years of age
    Galezowski, N
    Nguyen, TB
    Fajac, I
    PRESSE MEDICALE, 1996, 25 (25): : 1166 - 1166
  • [40] COVID-19 in Individuals with Severe Alpha 1-Antitrypsin Deficiency
    Tanash, Hanan
    Blakaj, Erona Tahiri
    Piitulainen, Eeva
    Zaigham, Suneela
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 2661 - 2669